Archford Capital Strategies LLC Has $259,000 Stake in UiPath Inc. (NYSE:PATH)
Archford Capital Strategies LLC Has $259,000 Stake in UiPath Inc. (NYSE:PATH)
Archford Capital Strategies LLC lifted its position in shares of UiPath Inc. (NYSE:PATH – Get Rating) by 10.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,237 shares of the healthcare company's stock after purchasing an additional 1,350 shares during the quarter. Archford Capital Strategies LLC's holdings in UiPath were worth $259,000 at the end of the most recent reporting period.
根據Archford Capital Strategy LLC向美國證券交易委員會(Securities&Exchange Commission)的最新披露,該公司在第二季度將其在UiPath Inc.(NYSE:Path-Get Rating)的股票頭寸提高了10.5%。該公司在本季度額外購買了1,350股票後,持有這家醫療保健公司的14,237股票。在最近一個報告期結束時,Archford Capital Strategy LLC持有的UiPath價值25.9萬美元。
A number of other institutional investors also recently modified their holdings of PATH. AdvisorNet Financial Inc raised its position in UiPath by 48.6% in the 2nd quarter. AdvisorNet Financial Inc now owns 3,120 shares of the healthcare company's stock valued at $57,000 after buying an additional 1,020 shares during the last quarter. Freestone Capital Holdings LLC raised its position in UiPath by 24.8% in the 4th quarter. Freestone Capital Holdings LLC now owns 5,307 shares of the healthcare company's stock valued at $229,000 after buying an additional 1,054 shares during the last quarter. Prospera Financial Services Inc purchased a new stake in UiPath in the 1st quarter valued at $27,000. First Republic Investment Management Inc. raised its position in UiPath by 1.6% in the 1st quarter. First Republic Investment Management Inc. now owns 91,074 shares of the healthcare company's stock valued at $1,966,000 after buying an additional 1,410 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. grew its stake in UiPath by 3.8% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 40,993 shares of the healthcare company's stock valued at $885,000 after purchasing an additional 1,506 shares during the period. 51.35% of the stock is owned by institutional investors and hedge funds.
其他一些機構投資者最近也調整了對Path的持股。AdvisorNet Financial Inc.在第二季度將其在UiPath的頭寸提高了48.6%。AdvisorNet Financial Inc現在擁有這家醫療保健公司的3,120股票,價值57,000美元,此前該公司在上個季度又購買了1,020股票。Frestone Capital Holdings LLC在第四季度將其在UiPath的頭寸提高了24.8%。Frestone Capital Holdings LLC現在擁有這家醫療保健公司5,307股股票,價值22.9萬美元,上個季度又購買了1,054股。普羅斯佩拉金融服務公司在第一季度購買了UiPath的新股份,價值2.7萬美元。第一共和投資管理公司(First Republic Investment Management Inc.)第一季度將其在UiPath的持倉提高了1.6%。First Republic Investment Management Inc.現在持有91,074股這家醫療保健公司的股票,價值1,966,000美元,在上個季度又購買了1,410股。最後,雷蒙德·詹姆斯金融服務顧問公司(Raymond James Financial Services Advisors Inc.)第一季度增持了UiPath 3.8%的股份。雷蒙德·詹姆斯金融服務顧問公司(Raymond James Financial Services Advisors Inc.)在此期間又購買了1,506股,現在擁有40,993股這家醫療保健公司的股票,價值885,000美元。51.35%的股票由機構投資者和對衝基金持有。
Insider Buying and Selling
內幕買賣
In related news, CFO Ashim Gupta sold 10,000 shares of the stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $13.74, for a total transaction of $137,400.00. Following the sale, the chief financial officer now owns 1,377,266 shares of the company's stock, valued at approximately $18,923,634.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UiPath news, CAO Hitesh Ramani sold 22,800 shares of the firm's stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $20.70, for a total value of $471,960.00. Following the sale, the chief accounting officer now owns 426,799 shares of the company's stock, valued at approximately $8,834,739.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Ashim Gupta sold 10,000 shares of the firm's stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $13.74, for a total value of $137,400.00. Following the completion of the sale, the chief financial officer now directly owns 1,377,266 shares in the company, valued at approximately $18,923,634.84. The disclosure for this sale can be found here. In the last quarter, insiders have sold 162,800 shares of company stock valued at $3,129,960. Corporate insiders own 31.88% of the company's stock.
在相關新聞中,首席財務官阿什姆·古普塔在一筆日期為9月8日星期四的交易中出售了10,000股該股。該股以13.74美元的平均價格出售,總成交金額為137,400.00美元。出售後,首席財務官現在擁有1,377,266股公司股票,價值約18,923,634.84美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過美國證券交易委員會網站。在UiPath的其他新聞中,CAO Hitesh Ramani在8月15日星期一的交易中出售了22,800股該公司的股票。這隻股票的平均售價為20.70美元,總價值為471,960.00美元。出售後,首席會計官現在擁有426,799股公司股票,價值約8,834,739.30美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過此超鏈接。此外,首席財務官阿什姆·古普塔在一筆日期為9月8日星期四的交易中出售了10,000股公司股票。這些股票的平均價格為13.74美元,總價值為137,400.00美元。出售完成後,首席財務官現在直接擁有該公司1,377,266股,價值約18,923,634.84美元。關於這次銷售的披露可以找到這裏。在上個季度,內部人士出售了162,800股公司股票,價值3,129,960美元。公司內部人士持有該公司31.88%的股份。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
UiPath Price Performance
UiPath性價比
Shares of PATH opened at $13.79 on Wednesday. The stock's 50-day simple moving average is $17.88 and its 200 day simple moving average is $19.81. UiPath Inc. has a 52-week low of $12.21 and a 52-week high of $59.57.
Path的股價週三開盤報13.79美元。該股的50日簡單移動均線切入位為17.88美元,200日簡單移動均線切入位為19.81美元。UiPath Inc.的股價為12.21美元,為52周低點,52周高點為59.57美元。
UiPath (NYSE:PATH – Get Rating) last issued its quarterly earnings data on Tuesday, September 6th. The healthcare company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.09. The business had revenue of $242.22 million for the quarter, compared to analysts' expectations of $230.68 million. UiPath had a negative return on equity of 19.19% and a negative net margin of 42.98%. The firm's quarterly revenue was up 23.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.17) EPS. Sell-side analysts anticipate that UiPath Inc. will post -0.63 earnings per share for the current year.
UiPath(NYSE:PATH-GET Rating)最近一次發佈季度收益數據是在9月6日星期二。這家醫療保健公司公佈了該季度每股收益(EPS)(0.02美元),比分析師普遍預期的(0.11美元)高出0.09美元。該業務當季營收為2.422億美元,高於分析師預期的2.3068億美元。UiPath的淨資產回報率為負19.19%,淨利潤率為負42.98%。該公司季度營收同比增長23.9%。在去年同一季度,該公司公佈了每股收益(0.17美元)。賣方分析師預計,UiPath Inc.將公佈本年度每股收益為0.63美元。
UiPath Profile
UiPath配置文件
(Get Rating)
(獲取評級)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
UiPath Inc.提供端到端自動化平臺,主要在美國、羅馬尼亞和日本提供一系列機器人過程自動化(RPA)解決方案。該公司提供一套相互關聯的軟件來構建、管理、運行、參與、測量和治理組織內的自動化。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on UiPath (PATH)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
- 在UiPath上免費獲取StockNews.com研究報告的副本(路徑)
- 3家航空公司股票陷入持有格局
- Roku股票下跌,但並未出局
- 如果你渴望價值,那就嚐嚐露絲的好客之道吧
- 福特在第三季度發出警告後是否正在反彈
- AMD股票是不是跌得太厲害了?
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Get Rating).
想看看其他對衝基金持有什麼路徑嗎?訪問HoldingsChannel.com獲取UiPath Inc.(紐約證券交易所代碼:Path-Get Rating)的最新13F文件和內幕交易。
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
接收UiPath Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對UiPath和相關公司的最新新聞和分析師評級的每日簡明摘要。